诱导多能干细胞技术的优化及其应用前景

doi:10.13523/j.cb.20160612

中国生物工程杂志

2016, Vol. 36

Issue (6): 87-91 DOI: 10.13523/j.cb.20160612

综述

诱导多能干细胞技术的优化及其应用前景

夏朦¹, 田晓红², 柏树令², 侯伟健²

1. 中国医科大学沈阳 110122;
2. 中国医科大学公共基础学院沈阳 110122

Optimization of Induced Pluripotent Stem Cell Technology and Its Application Prospect

XIA Meng¹, TIAN Xiao-hong², BAI Shu-ling², HOU Wei-jian²

1. The 1st Department of Clinical Medicine, China Medical University, Shenyang 110122, China;
2. Department of Tissue Engineering, School of Fundamental Science, China Medical University, Shenyang 110122, China

全文: PDF(505 KB) HTML

摘要：

诱导多能干细胞(induced pluripotent stem cells, iPSCs)是类似胚胎干细胞的一种细胞类型,可以通过对已分化的体细胞进行诱导重编程获得,具有自我更新能力和多潜能性,在体外疾病模型的建立、移植替代治疗、发育学等方面有广阔的应用前景,但致瘤性、转化率低、疾病模型拟合度差等缺点限制着iPS技术在临床和科研上的推广。对近几年诱导多能干细胞技术优化方面取得的新进展进行综述,重点阐述降低致瘤性和提高转化率的几种方法及iPS在临床和科研上的应用前景。

关键词： 重编程; 诱导多能干细胞; 致瘤性; 转化率

Abstract:

Induced pluripotent stem cells (iPSCs) are a type of cells similar to embryonic stem cells (ESCs) which have the characters of self-renewal and pluripotency.They can be obtained through the induced reprogramming of differentiated somatic cells.iPSC has broad application prospects in the establishment of disease models in vitro,regenerative medicine,embryology etc. The controversies and obstacles that challenge the field are its tumorigenicity,low transformation efficiency and the low degree of fitting of the disease models. The majorizations of method on reprogramming were summarized, and the ways to increase transformation efficiency and reduce tumorigenicity were emphasized.The application prospects of iPS in clinical therapy and scientific research in the future were explored

Key words: Tumorigenicity Induced pluripotent stem cells Transformation efficiency Reprogramming

收稿日期: 2016-03-21 出版日期: 2016-06-25

ZTFLH:

Q813.5

基金资助:

国家自然科学基金(30940095)、辽宁省教育厅基金(L2010575)资助项目

通讯作者: 侯伟健 E-mail: wjhou@mail.cmu.edu.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

引用本文:

夏朦, 田晓红, 柏树令, 侯伟健. 诱导多能干细胞技术的优化及其应用前景[J]. 中国生物工程杂志, 2016, 36(6): 87-91.

XIA Meng, TIAN Xiao-hong, BAI Shu-ling, HOU Wei-jian. Optimization of Induced Pluripotent Stem Cell Technology and Its Application Prospect. China Biotechnology, 2016, 36(6): 87-91.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20160612 或 https://manu60.magtech.com.cn/biotech/CN/Y2016/V36/I6/87

[1] Yamanaka S, Zhang X, Maeda M, et al.Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway. Embo J,2000, 19(20), 5533-5541.
[2] Takahashi K,Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4):663-676.
[3] Gao S, Zheng C, Chang G,et al.Unique features of mutations revealed by sequentially reprogrammed induced pluripotent stem cells.Nature Communication, 2015 Feb 18;6:6318. doi: 10.1038/ncomms7318.
[4] Okita K, Nakagawa M, Hyenjong H, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science, 2008, 322(5903):949-953.
[5] Mali P, Ye Z, Hommond H, et al. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells, 2008, 26(8):1998-2005.
[6] Shimada H, Hashimoto Y, Nakada A, et al. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia.Biochem Biophys Res Commun, 2012,417(2):659-664.
[7] Zhou H, Wu S, Joo J. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell,2009,4(5):381-384.
[8] Liu S,Ham H, Chien Y, et al. N-butylidenephthalide (bp) maintains stem cell pluripotency by activating jak2/stat3 pathway and increases the efficiency of ips cells generation. PLoS One, 2012,7(9):e44024.
[9] Quarto N, Li S, Renda A,et al. Exogenous activation of bmp-2 signaling overcomes tgf beta-mediated inhibition of osteogenesis in marfan embryonic stem cells and marfan patient-specific induced pluripotent stem cells. Stem Cells, 2012, 30(12):2709-2719.
[10] Salewski R, Buttigieg J, Mitchell R,et al. The generation of definitive neural stem cells from piggybac transposon-induced pluripotent stem cells can be enhanced by induction of the notch signaling pathway. Stem Cells Dev, 2012, 22(3):383-396.
[11] Hudson J,Zimmermann W. Tuning wnt-signaling to enhance cardiomyogenesis in human embryonic and induced pluripotent stem cells. J Mol Cell Cardiol, 2011, 51(3):277-279.
[12] Zhang Z,Gao Y, Gordon A,et al. Efficient generation of fully reprogrammed human ips cells via polycistronic retroviral vector and a new cocktail of chemical compounds. PLoS One, 2011, 6(10):e26592.
[13] Somoza R A, Rubio F J. Cell therapy using induced pluripotent stem cells or somatic stem cells: This is the question. Curr Stem Cell Res Ther, 2012, 7(3):191-196.
[14] Huang H P, Chen P H, Hwu W L, et al. Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. Hum Mol Genet, 2011,20(24):4851-4864.
[15] Hou P, Li Y, Zhang X, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science,2013, 341(6146):651-654.
[16] Young M A, Larson D E, Sun C W,et al.Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells.Cell Stem Cell, 2012,10(5):570-582.
[17] Laurent L C, Ulitsky I, Slavin I,et al.Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.Cell Stem Cell,2011,8(1):106-118.
[18] Krupalnik V,Hanna J H. Stem cells: The quest for the perfect reprogrammed cell. Nature, 2014,511(7508):160-161.
[19] Ambasudhan R, Talantova M, Coleman R, et al. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell, 2011, 9(2): 113-118.
[20] Huang P, He Z, Ji S,et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature, 2011, 475(7356): 386-389.
[21] Hong H, Takahashi K, Ichisaka T, et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.Nature,2009,460(7259):1132-1135.
[22] Brons I, Gabrielle M L,Smithers L E, et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature,2007,448(7150): 191-195.
[23] Rais Y,Zviran A,Geula S, et al.Deterministic direct reprogramming of somatic cells to pluripotency. Nature, 2015,520(7549):710-730.
[24] Yu K R, Shin J H, Kim J J,et al, Rapid and efficient direct conversion of human adult somatic cells into neural stem cells by HMGA2/let-7b.Cell Reports,2015,110(3)441-452.
[25] Aasen T, Raya A, Barrero M J, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol, 2008, 26(11):1276-1284.
[26] Aoki T, Ohnishi H, Oda Y,et al. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-myc. Tissue Eng Part A, 2010, 16(7):2197-2206.
[27] Ieda M, Fu J D, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell, 2010, 142(3): 375-386.
[28] Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic cells into induced pluripotent stem cells. Current Biology,2008, 18(12):890-894.
[29] Dimos J T, Rodolfa K T, Niakan K K, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.Science.,2008,321(5893):1218-1221.
[30] Richard S,Sebastian G,Elena N, et al. Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells. Stem Cell Reports,2015,4(5):939-952.
[31] Hayashi K,Ogushi S,Kurimoto K,et al. Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice.Science,2012,338(6109):971-975.
[32] 陈默. 移植诱导多能干细胞(iPSCs)修复化疗所致卵巢早衰的实验研究.上海:复旦大学,2014. Chen M. IPSCs transplantation restores follicular maturation and steroid hormonesproduction in a mouse model of chemotherapy-induced ovarian failure. Shanghai:Fudan University,2014.
[33] Dimos J T, Rodolfa K T, Niakan K K, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science,2008, 321(7):1218-1221.
[34] Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell,2009,136(3): 964-977.
[35] Bihel E, Pro-Sistiaga P, Letourneur A,et al.Permanent or transient chronic ischemic stroke in the non-human primate: behavioral, neuroimaging,histological,and immunohistochemical investigations.J Cereb Blood Flow Metab,2010,30(2):273-285.
[36] Philippens I H, Hart B A, Torres G.The MPTP marmoset model of parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases.Drug Discov Today, 2010,15(23-24):985-990.
[37] Zhou Q, Brown J, Kanarek A,et al. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature, 2008, 455(7213): 627-633.
[38] 陈凌. iPS细胞诱导的肿瘤干细胞模型及应用. 中国城乡企业卫生,2014,06:26-27. Chen L.The establishment and application of the cancer stem cell model induced from iPS cells. China's Urban and Rural Health Enterprise,2014, 06:26-27.

[1]	邱丹丹,陆彩霞,代解杰. 诱导多能干细胞来源的肝细胞在HCV感染模型中的应用^*[J]. 中国生物工程杂志, 2020, 40(11): 67-72.
[2]	李欣,赵中利,罗晓彤,曹阳,张立春,于永生,金海国. 诱导多能干细胞向雄性生殖细胞分化诱导物的研究进展 ^*[J]. 中国生物工程杂志, 2019, 39(4): 94-100.
[3]	李玲玉, 何松蔚, 郑辉. 维生素C对细胞增殖的挽救提高shDNMT1对重编程的促进作用[J]. 中国生物工程杂志, 2016, 36(6): 1-8.
[4]	郝问, 缪黄泰, 师树田, 聂绍平. 直接重编程用于心脏再生治疗的研究进展[J]. 中国生物工程杂志, 2015, 35(12): 84-88.
[5]	赵丽霞, 张金吨, 张健, 李云霞, 苏杰, 孙伟, 赵高平, 戴雁峰, 郭继彤, 胡树香, WANG Wei, LIU Pen-tao, 李喜和. 利用piggyBac转座子制备牛成体多能干细胞诱导技术研究[J]. 中国生物工程杂志, 2013, 33(2): 77-82.
[6]	范勇, 骆玉梅, 陈欣杰, 孙筱放. 无饲养层和动物源蛋白的β-地中海贫血诱导多能干细胞系的建立[J]. 中国生物工程杂志, 2012, 32(6): 69-73.
[7]	孙昊, 卢存福, 郭允倩. LSD1通过和Oct4/Nanog相互作用调节诱导多能干细胞的形成[J]. 中国生物工程杂志, 2012, 32(12): 25-29.
[8]	马海滨, 侯玲玲, 王晓宇, 关伟军, 马月辉. 诱导性多潜能干细胞(iPS细胞)的研究进展[J]. 中国生物工程杂志, 2011, 31(8): 124-132.
[9]	付蒙, 张艳梅, 王佃亮, 曾虹燕, 孙晋伟. 人羊膜间充质干细胞的生物学特性及临床前研究[J]. 中国生物工程杂志, 2011, 31(12): 115-119.
[10]	屈娅徐海伟阴正勤. 电融合技术进展及其在干细胞研究中的应用[J]. 中国生物工程杂志, 2010, 30(07): 0-0.
[11]	苗茂栋,吴敏,邵千飞,马全红,蒋知欲. 利用克雷伯肺炎杆菌限制性底物发酵生产1，3-丙二醇[J]. 中国生物工程杂志, 2008, 28(10): 49-54.
[12]	褚明辉, 郭建强, 高殿昆, 孙淑兰, 肖毅, 王连琴. 用新的紫外荧光光源对维生素D2的最佳光合成[J]. 中国生物工程杂志, 1999, 19(5): 25-26,28-29.
[13]	陈盛, 李柱来. 壳聚糖固定化脲酶研究Ⅱ[J]. 中国生物工程杂志, 1992, 12(5): 40-43,17.
[14]	许光学, 卢泽俭, 林少琨, 林尚安. 人工种子种皮的研究现状[J]. 中国生物工程杂志, 1990, 10(5): 14-23.
[15]	B.K.Hamilton, 梅芳. 用生物反应器生产L-氨基酸[J]. 中国生物工程杂志, 1986, 6(4): 33-38.

Viewed

Full text

Abstract

Cited

Shared

Discussed